Literature DB >> 22658525

Effects of polypharmacy on sleep in psychiatric inpatients.

Flavie Waters1, Deborah Faulkner, Neepa Naik, Daniel Rock.   

Abstract

The relationship between psychotropic drugs and sleep remains poorly understood. In this study, we examined the relationship between the number (and dosage) of concurrently-taken antipsychotic medications and sleep in a psychiatric inpatient population. Eighty-three long-stay inpatients with severe mental disorders were administered the Pittsburgh Sleep Quality Index questionnaire (PSQI). Results showed that increasing antipsychotics dosages were linked to better sleep, although antipsychotic medications only accounted for a relatively small amount of the variance in sleep quality. The results also showed that, when taken in combination with several antipsychotics, SSRI/SNRI antidepressants failed to show the expected disruptive effects on sleep patterns and daytime functions. Altogether, sleep complaints remained pervasive in 70% of this medicated clinical sample. This suggests that the use of the sedative properties of antipsychotic medication has limited efficacy as a treatment option for sleep dysfunctions, and is not an appropriate substitute for other sleep interventions. Altogether, the results support the case for more systematic screening and interventions for sleep problems in patients with severe psychiatric illness.
Copyright © 2012 Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22658525     DOI: 10.1016/j.schres.2012.05.013

Source DB:  PubMed          Journal:  Schizophr Res        ISSN: 0920-9964            Impact factor:   4.939


  13 in total

Review 1.  Psychiatric Illness and Parasomnias: a Systematic Review.

Authors:  Flavie Waters; Umberto Moretto; Thien Thanh Dang-Vu
Journal:  Curr Psychiatry Rep       Date:  2017-07       Impact factor: 5.285

2.  The association of continuous-use medications and sleep parameters in a sample of working adults.

Authors:  Marcela Zambrim Campanini; Alberto Duran González; Selma Maffei de Andrade; Edmarlon Girotto; Marcos Aparecido Sarriá Cabrera; Iván Cavero-Redondo; Arthur Eumann Mesas
Journal:  Sleep Breath       Date:  2021-03-13       Impact factor: 2.816

3.  Restless leg syndrome in hospitalized psychiatric patients in Lebanon: a pilot study.

Authors:  Farid Talih; Jean Ajaltouni; Firas Kobeissy
Journal:  Neuropsychiatr Dis Treat       Date:  2016-10-11       Impact factor: 2.570

4.  Experiences, perspectives and priorities of people with schizophrenia spectrum disorders regarding sleep disturbance and its treatment: a qualitative study.

Authors:  Sophie Faulkner; Penny Bee
Journal:  BMC Psychiatry       Date:  2017-05-02       Impact factor: 3.630

Review 5.  Excessive Daytime Sleepiness in Parkinson's Disease: Clinical Implications and Management.

Authors:  Yun Shen; Jun-Ying Huang; Jie Li; Chun-Feng Liu
Journal:  Chin Med J (Engl)       Date:  2018-04-20       Impact factor: 2.628

Review 6.  Pharmacologic Treatment Options for Insomnia in Patients with Schizophrenia.

Authors:  Lauren Stummer; Marija Markovic; Megan E Maroney
Journal:  Medicines (Basel)       Date:  2018-08-11

Review 7.  Sleep Abnormalities in Schizophrenia: State of the Art and Next Steps.

Authors:  Fabio Ferrarelli
Journal:  Am J Psychiatry       Date:  2021-03-17       Impact factor: 18.112

8.  Sleep, fatigue, and functional health in psychotic patients.

Authors:  Flavie Waters; Neepa Naik; Daniel Rock
Journal:  Schizophr Res Treatment       Date:  2013-04-30

9.  Preferences for different insomnia treatment options in people with schizophrenia and related psychoses: a qualitative study.

Authors:  Flavie Waters; Vivian W Chiu; Aleksandar Janca; Amanda Atkinson; Melissa Ree
Journal:  Front Psychol       Date:  2015-07-14

10.  Insomnia in hospitalized psychiatric patients: prevalence and associated factors.

Authors:  Farid Talih; Jean Ajaltouni; Hiba Ghandour; Ahmad Subhi Abu-Mohammad; Firas Kobeissy
Journal:  Neuropsychiatr Dis Treat       Date:  2018-04-10       Impact factor: 2.570

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.